Telomir Pharmaceuticals, Inc. Quarterly Common Stock, Shares Authorized from Q4 2022 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Telomir Pharmaceuticals, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2022 to Q3 2024.
  • Telomir Pharmaceuticals, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 300M shares.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 300M Sep 30, 2024 10-Q 2024-11-12
Q2 2024 300M Jun 30, 2024 10-Q 2024-08-13
Q1 2024 300M Mar 31, 2024 10-Q 2024-05-13
Q4 2023 300M 0 0% Dec 31, 2023 10-Q 2024-11-12
Q4 2022 300M Dec 31, 2022 10-K 2024-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.